Ignite Creation Date:
2024-07-17 @ 11:04 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06493279
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-09
First Post:
2024-07-02
Brief Title:
Evaluate the Safety and Efficacy of Intrathecal Injection of RJK002 in Patients With Amyotrophic Lateral Sclerosis
Sponsor:
Rejukon Biopharm Inc
Organization:
Rejukon Biopharm Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-08-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2031-03-02
Completion Date Type:
ESTIMATED
First Submit Date:
2024-07-02
First Submit QC Date:
None
Study First Post Date:
2024-07-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-14
Last Update Post Date:
2024-07-09
Last Update Post Date Type:
ACTUAL